Jason Dinges

Jason Dinges has been a member of the investment team at Morningside since 2011, and has extensive experience providing operational and management oversight to early-stage biotechnology companies. He serves on the boards of Morningside’s portfolio companies Matatu, Inc., Cancer Targeting Systems, Inc., 2020, Inc., and Vigeo, Inc. Jason received his B.S. from Illinois Wesleyan University, a Ph.D. in genetics from Iowa State University, and his J.D. from the University of Iowa College of Law, with highest distinction. He spent 5 years as an intellectual property attorney with Foley & Lardner LLP, before joining Morningside Technology Advisory LLC.